Medtech Matters
Un pódcast de Medical Product Outsourcing
155 Episodo
-
Should Wellness Products Come with a Warning?
Publicado: 11/9/2025 -
3 Most Common Premarket (Postmarket?) Review Issues FDA Sees
Publicado: 25/6/2025 -
Why Are One-Third of MAUDE Reports a Problem?
Publicado: 10/6/2025 -
FDA Guidance on Off-Label Communication, Part 1
Publicado: 30/5/2025 -
FDA Guidance on Off-Label Communication, Part 2
Publicado: 30/5/2025 -
Development Considerations for Over-the-Counter Medtech, Part 1
Publicado: 23/1/2025 -
Development Considerations for OTC Medtech, Part 2
Publicado: 23/1/2025 -
Device Descriptions in Regulatory Submissions
Publicado: 7/1/2025 -
Regulatory Ramifications Due to the Presidential Election
Publicado: 26/11/2024 -
Regulatory Considerations with an Assisted Suicide Machine
Publicado: 20/11/2024 -
Predetermined Change Control Plans, Part 2
Publicado: 24/9/2024 -
Predetermined Change Control Plans, Part 1
Publicado: 24/9/2024 -
What is a CAPA and How Do You Best Use It?
Publicado: 3/9/2024 -
You Got a 483 from the FDA. Now what?
Publicado: 22/8/2024 -
Revisiting Real-World Evidence
Publicado: 18/6/2024 -
The Most Dangerous Devices to Hit the Market
Publicado: 11/6/2024 -
Headline-Generating Medical Device Safety Concerns
Publicado: 2/5/2024 -
Analyzing ECRI’s 2024 Top 10 Health Technology Hazards
Publicado: 19/3/2024 -
Examining Institutional Review Boards
Publicado: 6/3/2024 -
Reimbursing Breakthrough Designation Products
Publicado: 2/1/2024
A podcast focused on the medical device technology industry, from design and development to outsourcing services and relationships to finished medtech products.
